CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

Janssen Vaccines & Prevention B.v.

patents

4 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 2018-2024

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11918639 - Methods and compositions for inducing protective immunity against filovirus infection (2024-03-05),

2. 11654189 - Compositions and methods for enhancing the stability of transgenes in poxviruses (2023-05-23),

3. 11338030 - Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogens (2022-05-24),

4. 11173201 - Methods and compositions for inducing protective immunity against filovirus infection (2021-11-16),

5. 11052139 - Compositions and methods for enhancing the stability of transgenes in poxviruses (2021-07-06),

6. 10925956 - Methods and compositions for inducing protective immunity against a marburg virus infection (2021-02-23),

7. 10576141 - Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogenic compositions and methods of use (2020-03-03),

8. 10561722 - Methods and compositions for enhancing immune responses (2020-02-18),

9. 10561721 - Methods and compositions for inducing protective immunity against filovirus infection (2020-02-18),

10. 10111946 - Poxviral vectors for low antibody response after a first priming immunization (2018-10-30),

Title: Innovations and Contributions of Ulrike Dirmeier in Immunology

Introduction

Ulrike Dirmeier, located in Starnberg, Germany, is a distinguished inventor known for her significant contributions to the field of immunology. With a portfolio of 10 patents, her work focuses on developing methods and compositions to enhance protective immunity against viral infections.

Latest Patents

Among Dr. Dirmeier's latest patents is the invention titled "Methods and compositions for inducing protective immunity against filovirus infection." This innovative work provides compositions, vaccines, and methods aimed at inducing protective immunity against filovirus infections, particularly targeting various subtypes of Ebola and Marburg viruses. Another notable patent is "Compositions and methods for enhancing the stability of transgenes in poxviruses." This invention highlights recombinant poxviruses that maintain stability through successive passaging, incorporating modified nucleic acids that encode crucial antigens such as MUC1, CEA, and TRICOM.

Career Highlights

Throughout her career, Dr. Dirmeier has made impactful strides in vaccine development and viral research. She has played a vital role in advancing techniques to combat serious viral threats, showcasing her commitment to public health and safety.

Collaborations

Dr. Dirmeier’s professional journey includes valuable collaborations with esteemed organizations such as Bavarian Nordic A/S and Janssen Vaccines & Prevention B.V. Moreover, she has worked alongside talented colleagues like Robin Steigerwald and Ariane Volkmann, contributing to the synergy and innovative output of their research teams.

Conclusion

Ulrike Dirmeier is a remarkable inventor whose work significantly influences the landscape of immunology and vaccine development. Through her patents and collaborative efforts, she continues to pave the way for advancements in protective therapies against viral infections, earning her a notable place among leading innovators in her field.

This text is generated by artificial intelligence and may not be accurate.